UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2018	$ 37	$ 121	$ (11,290)	$ 100,123	$ 88,991
Equity Balance, shares at Dec. 31, 2018	3,720
Common stock issued upon exercise of employee stock options	$ 0	97	0	0	97
Common stock issued upon exercise of employee stock options, shares	3
Stock option compensation expense	$ 0	28	0	0	28
Common stock purchased and retired	0	0	0	0	0
Foreign currency translation adjustment	0	0	948	0	948
Common stock dividends	0	0	0	(1,028)	(1,028)
Net income	0	0	0	3,139	3,139
Equity Balance, value at Mar. 31, 2019	$ 37	246	(10,342)	102,234	92,175
Equity Balance, shares at Mar. 31, 2019	3,723
Equity Balance, value at Dec. 31, 2018	$ 37	121	(11,290)	100,123	88,991
Equity Balance, shares at Dec. 31, 2018	3,720
Foreign currency translation adjustment					484
Net income					6,664
Equity Balance, value at Jun. 30, 2019	$ 37	0	(10,806)	104,681	93,912
Equity Balance, shares at Jun. 30, 2019	3,719
Equity Balance, value at Mar. 31, 2019	$ 37	246	(10,342)	102,234	92,175
Equity Balance, shares at Mar. 31, 2019	3,723
Common stock issued upon exercise of employee stock options	$ 0	74	0	0	74
Stock option compensation expense	0	28	0	0	28
Common stock purchased and retired	$ 0	(348)	0	(50)	(398)
Common stock purchased and retired, shares	(5)
Foreign currency translation adjustment	$ 0	0	(464)	0	(464)
Common stock dividends	0	0	0	(1,028)	(1,028)
Net income	0	0	0	3,525	3,525
Equity Balance, value at Jun. 30, 2019	$ 37	0	(10,806)	104,681	93,912
Equity Balance, shares at Jun. 30, 2019	3,719
Equity Balance, value at Dec. 31, 2019	$ 37	18	(9,783)	110,820	101,092
Equity Balance, shares at Dec. 31, 2019	3,722
Common stock issued upon exercise of employee stock options	$ 0	47	0	0	48
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	23	0	0	23
Common stock purchased and retired	$ (1)	(89)	0	(6,336)	(6,426)
Common stock purchased and retired, shares	(80)
Foreign currency translation adjustment	$ 0	0	(2,449)	0	(2,449)
Common stock dividends	0	0	0	(1,042)	(1,042)
Net income	0	0	0	3,140	3,140
Equity Balance, value at Mar. 31, 2020	$ 36	0	(12,232)	106,582	94,386
Equity Balance, shares at Mar. 31, 2020	3,642
Equity Balance, value at Dec. 31, 2019	$ 37	18	(9,783)	110,820	101,092
Equity Balance, shares at Dec. 31, 2019	3,722
Foreign currency translation adjustment					(1,927)
Net income					4,452
Equity Balance, value at Jun. 30, 2020	$ 36	80	(11,710)	106,881	95,287
Equity Balance, shares at Jun. 30, 2020	3,643
Equity Balance, value at Mar. 31, 2020	$ 36	0	(12,232)	106,582	94,386
Equity Balance, shares at Mar. 31, 2020	3,642
Common stock issued upon exercise of employee stock options	$ 0	32	0	0	32
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	49	0	0	49
Common stock purchased and retired	0	0	0	0	0
Foreign currency translation adjustment	0	0	522	0	522
Common stock dividends	0	0	0	(1,013)	(1,013)
Net income	0	0	0	1,313	1,313
Equity Balance, value at Jun. 30, 2020	$ 36	$ 80	$ (11,710)	$ 106,881	$ 95,287
Equity Balance, shares at Jun. 30, 2020	3,643